(Q47961048)

7 February 2018

title

Controlled release of antibodies for long-term topical passive immunoprotection of female mice against genital herpes (English)

1 reference

7 February 2018

1 reference

Sherwood JK

1

1 reference

7 February 2018

Zeitlin L

2

1 reference

7 February 2018

Whaley KJ

3

1 reference

7 February 2018

Cone RA

4

1 reference

7 February 2018

Saltzman M

5

1 reference

7 February 2018

publication date

1 April 1996

1 reference

7 February 2018

published in

Nature Biotechnology

1 reference

7 February 2018

volume

14

1 reference

7 February 2018

issue

4

1 reference

7 February 2018

page(s)

468-471

1 reference

7 February 2018

https://scigraph.springernature.com/pub.10.1038/nbt0496-468

exact match

0 references

cites work

Herpes simplex virus infection as a risk factor for human immunodeficiency virus infection in heterosexuals

1 reference

https://api.crossref.org/works/10.1038%2FNBT0496-468

Monoclonal antibodies for reproductive health: Part I. Preventing sexual transmission of disease and pregnancy with topically applied antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0496-468

Underdiagnosis of Genital Herpes by Current Clinical and Viral-Isolation Procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0496-468

7 January 2021

Women: absent term in the AIDS research equation.

1 reference

https://api.crossref.org/works/10.1038%2FNBT0496-468

7 January 2021

Potent neutralizing activity associated with anti-glycoprotein D specificity among monoclonal antibodies selected for binding to herpes simplex virions

1 reference

https://api.crossref.org/works/10.1038%2FNBT0496-468

7 January 2021

Anti-glycoprotein D antibodies that permit adsorption but block infection by herpes simplex virus 1 prevent virion-cell fusion at the cell surface

1 reference

https://api.crossref.org/works/10.1038%2FNBT0496-468

7 January 2021

Passive immunization of the vagina protects mice against vaginal transmission of genital herpes infections

1 reference

https://api.crossref.org/works/10.1038%2FNBT0496-468

7 January 2021

Residence half-life of IgG administered topically to the mouse vagina

1 reference

https://api.crossref.org/works/10.1038%2FNBT0496-468

7 January 2021

Challenges for the development of female-controlled vaginal microbicides

1 reference

https://api.crossref.org/works/10.1038%2FNBT0496-468

7 January 2021

Clinical experience with the uterine progesterone system (Progestasert®)

1 reference

https://api.crossref.org/works/10.1038%2FNBT0496-468

7 January 2021

Biocompatibility of polymeric delivery systems for macromolecules

1 reference

https://api.crossref.org/works/10.1038%2FNBT0496-468

7 January 2021

Polymers for sustained macromolecule release: procedures to fabricate reproducible delivery systems and control release kinetics

1 reference

https://api.crossref.org/works/10.1038%2FNBT0496-468

7 January 2021

Transport rates of proteins in porous materials with known microgeometry

1 reference

https://api.crossref.org/works/10.1038%2FNBT0496-468

7 January 2021

Antibody diffusion in human cervical mucus

1 reference

https://api.crossref.org/works/10.1038%2FNBT0496-468

7 January 2021

Controlled vaginal delivery of antibodies in the mouse

1 reference

https://api.crossref.org/works/10.1038%2FNBT0496-468

7 January 2021

Controlled release of polypeptides and other macromolecules

1 reference

https://api.crossref.org/works/10.1038%2FNBT0496-468

7 January 2021

The effects of frequent nonoxynol-9 use on the vaginal and cervical mucosa.

1 reference

https://api.crossref.org/works/10.1038%2FNBT0496-468

7 January 2021

Nonoxynol-9 protects mice against vaginal transmission of genital herpes infections

1 reference

https://api.crossref.org/works/10.1038%2FNBT0496-468

7 January 2021

Identifiers

DOI

10.1038/NBT0496-468

1 reference

7 February 2018

1 reference

7 February 2018